Chondroprotection, chondroitin sulfate, glucosamine, hyaluronic acid

Español | English

You are about to enter a section of information on our drug products.

"The content of the web site you are about to enter may be considered advertising on prescription drugs. According to the Royal Decree 1416/1994 of June 25 on the Regulation of Advertising of Drugs for Human Use and the Law 29/2006 of July 26 on Guarantees and Reasonable Use of Drugs and Health Products, the advertising content on prescription drugs provided by Bioibérica in this section is solely intended for health professionals authorized to prescribe and provide drugs.

I am a health professional authorized to prescribe and provide drugs in Spain"

THE BIOIBÉRICA PHARMA DIVISION specializes in researching and developing effective drugs that offer enhanced therapeutic alternatives in CHONDROPROTECTION to prevent, delay, stabilize, and repair or reverse damage to the cartilage, synovial membrane and/or subchondral bone.

In Spain there are currently 3 chondroprotective drugs indicated for the treatment of arthrosis: chondroitin Sulfate, glucosamine Sulfate, and hyaluronic acid.